Research projects and
cooperative projects

wissenschaftliche und kooperative Projekte


Real world effectiveness and safety of brexucabtagene autoleucel versus patient-individual therapy in relapsed/refractory mantle cell lymphoma

Status: Active

Type, Partner: Kite/Gilead

Year: 2023

Type of analysis: Aggregated


Late POD 

Status: Active

Type, Partner: FIL, Visco

Year: 2022

Key parameters: Patients with positive disease course - characteristics

Type of analysis: Patient level


Fate of BTK-failures

Status: Active

Type, Partner: Lilly

Year: 2022

Type of analysis: Aggregated


Retrospective database research of real-world treatment patterns in Mantle Cell Lymphoma (MCL) patients in Germany, Italy and Europe

Status: Acitve

Type, Partner: Janssen

Year: 2022

Type of analysis: Aggregated


Retrospective analysis of real-world treatment patterns in Mantle Cell Lymphoma patients in Germany

Status: Active

Type, Partner: AbbVie

Year: 2022

Type of analysis: Aggregated


Prognosis of patients with Mantle Cell Lymphoma – Covid19

Status: Completed, follow up

Type, Partner: None

Year: 2022

Key parameters: Outcome of Covid-19- in patients with mantle cell lymphoma

Type of analysis: Internal analysis

Publication: DOI: 10.1097/HS9.0000000000000711


SCHOLAR 2: Ibrutinib Failure: Fate and health care utilization

Status: Completed

Type, Partner: Entity, Gilead

Year: 2019-2021

Key parameters: Outcome after BTKi-failure, Health care utilization

Type of analysis: Aggregated, individual if indispensable

Publication: DOI: 10.1111/bjh.18519


Treatment trends in MCL

Status: Completed

Type, Partner: Entity, Janssen

Year: 2019+

Type of analysis: Aggregated


Use of Lenalidomide in MCL treatment

Status: Closed

Type, Partner: Entity, Celgene

Year: 2017+

Key parameters: Number of patients treated with Lenalidomide for MCL

Type of analysis: Aggregated, Contact to treatment centers using drug


Fate of extranodal MCL

Status: Active

Type, Partner: Academic, FIL, EMCL-Verein

Year: 2016+

Key parameters: Extranodal manifestation

Type of analysis: Patient level